These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7864945)

  • 41. A new dilution for the modified APTT-based assay for activated protein C resistance: improvement of the reliability in patients with a lupus anticoagulant.
    Benattar N; Schved JF; Biron-Andréani C
    Thromb Haemost; 2000 Jun; 83(6):967-8. PubMed ID: 10896260
    [No Abstract]   [Full Text] [Related]  

  • 42. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.
    Zöller B; Dahlbäck B
    Lancet; 1994 Jun; 343(8912):1536-8. PubMed ID: 7911873
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Activated protein C resistance in the Japanese].
    Ozawa T
    Rinsho Ketsueki; 1996 Sep; 37(9):790-3. PubMed ID: 8914464
    [No Abstract]   [Full Text] [Related]  

  • 44. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R; Ens GE
    Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of modified functional assays for activated protein C resistance in patients with basally prolonged aPTT.
    Montaruli B; Schinco P; Pannocchia A; Giorgianni A; Borchiellini A; Tamponi G; Pileri A
    Thromb Haemost; 1997 Sep; 78(3):1042-8. PubMed ID: 9308751
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of rivaroxaban influence on a prothrombinase-based assay for the detection of activated C protein resistance: an Italian ex vivo and in vitro study in normal subjects and factor V Leiden carriers.
    Gessoni G; Valverde S; Valle L; Gessoni F; Caruso P; Valle R
    Int J Lab Hematol; 2017 Aug; 39(4):418-422. PubMed ID: 28318106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sensitivity to activated protein C; influence of oral contraceptives and sex.
    Henkens CM; Bom VJ; Seinen AJ; van der Meer J
    Thromb Haemost; 1995 Mar; 73(3):402-4. PubMed ID: 7667823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequency of resistance to activated protein C due to factor V mutation in young patients with ischemic stroke.
    Albucher JF; Guiraud-Chaumeil B; Chollet F; Cadroy Y; Sié P
    Stroke; 1996 Apr; 27(4):766-7. PubMed ID: 8614946
    [No Abstract]   [Full Text] [Related]  

  • 49. Understanding activated protein C resistance.
    Fairweather RB
    CAP Today; 1995 Nov; 9(11):60-2. PubMed ID: 10159123
    [No Abstract]   [Full Text] [Related]  

  • 50. [Resistance to activated protein C--a novel cause of thrombophilia].
    Cycowitz Z; Seligsohn U; Zivelin A; Eldor A
    Harefuah; 1995 Jul; 129(1-2):1-5, 80. PubMed ID: 7557699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid detection of factor V: Q506 mutation using whole blood protein C resistance.
    Sacchi E; Duca F; Tagliabue L
    Blood Coagul Fibrinolysis; 1996 Nov; 7(8):799-800. PubMed ID: 9034562
    [No Abstract]   [Full Text] [Related]  

  • 52. Whole blood screening test for factor V Leiden using a Russell viper venom time-based assay.
    Akhtar MS; Blair AJ; King TC; Sweeney JD
    Am J Clin Pathol; 1998 Apr; 109(4):387-91. PubMed ID: 9535390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pulmonary embolism disclosing activated protein C resistance].
    Strecker A; Bernardi F; Wolschies E; Hendricx S; Jude B
    Rev Mal Respir; 1996 Oct; 13(5):521-2. PubMed ID: 8999481
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inherited resistance to activated protein C, a major basis of venous thrombosis, is caused by deficient anticoagulant cofactor function of factor V.
    Dahlbäck B
    Haematologica; 1995; 80(2 Suppl):102-13. PubMed ID: 7628762
    [No Abstract]   [Full Text] [Related]  

  • 55. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene.
    Dahlbäck B
    Haemostasis; 1994; 24(2):139-51. PubMed ID: 7959362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resistance to activated protein C and factor V Leiden.
    Perry DJ; Pasi KJ
    QJM; 1997 Jun; 90(6):379-85. PubMed ID: 9205675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis of APC resistance in patients on standard or low molecular weight heparin.
    Gilmore G; Thom J; Baker RI
    Thromb Haemost; 1996 Feb; 75(2):372-3. PubMed ID: 8815593
    [No Abstract]   [Full Text] [Related]  

  • 58. APC-resistance and Mnl I genotype (Gln 506) of coagulation factor V are rare in Japanese population.
    Takamiya O; Ishida F; Kodaira H; Kitano K
    Thromb Haemost; 1995 Sep; 74(3):996. PubMed ID: 8571340
    [No Abstract]   [Full Text] [Related]  

  • 59. [Activated protein C resistance: role in venous and arterial thrombosis].
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Resistance to activated protein C and a novel factor V gene mutation.
    Voelkerding KV
    Clin Lab Med; 1996 Mar; 16(1):169-86. PubMed ID: 8867589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.